The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, ...

While AI has accelerated drug discovery, the same technology can address clinical trial bottlenecks that have persisted for ...

The Supreme Court wrapped up its arguments for the November sitting yesterday and announced what cases it will hear in January. Mark your calendars accordingly – we certainly have! SCOTUS […] The post ...